RTI Surgical Inc (RTIX)

4.55
0.00 (0.00)
NASDAQ : Health Care
Prev Close 4.55
Open 4.50
Day Low/High 4.50 / 4.53
52 Wk Low/High 2.81 / 7.48
Volume 13.02K
Avg Volume 218.90K
Exchange NASDAQ
Shares Outstanding 59.51M
Market Cap 270.77M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

RTI Surgical Becomes Oversold (RTIX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

RTI Surgical® Announces 2017 Second Quarter Results

RTI Surgical® Announces 2017 Second Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the second quarter of 2017.

RTI Surgical® Divests Cardiothoracic Closure Business To A&E Medical Corporation For Up To $60 Million

RTI Surgical® Divests Cardiothoracic Closure Business To A&E Medical Corporation For Up To $60 Million

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced that it has sold its cardiothoracic closure business to A&E Advanced Closure Systems, LLC (A&E Medical), a leading...

RTI Surgical® Schedules 2017 Second Quarter Earnings Call For August 8, 2017

RTI Surgical® Schedules 2017 Second Quarter Earnings Call For August 8, 2017

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the second quarter 2017 on Tuesday, August 8, 2017, prior to the market open.

Commit To Purchase RTI Surgical At $5, Earn 22.7% Annualized Using Options

Investors eyeing a purchase of RTI Surgical, Inc. stock, but tentative about paying the going market price of $5.15/share, might benefit from considering selling puts among the alternative strategies at their disposal.

RTIX: Insiders vs. Shorts

The most recent short interest data was recently released for the 05/15/2017 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 5.64 "days to cover" versus the median component at 4.71.

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.

RTI Surgical® Partners In New Manufacturing USA Institute

RTI Surgical (RTI) (Nasdaq: RTIX), a global surgical implant company, is part of a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI).

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOSL, AVD, BCC, BGSF, CDR, CTRE, DV, LUK, PHX, PRLB, RTIX, SFM, STAY, TRP, WAGE, ZAGG Downgrades: ABCO, ACIW, AMAG, CQP, HDNG, INT, NEWM, RGS, SGEN, SSP, TAC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

RTI Surgical® Announces 2017 First Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the first quarter of 2017.

RTI Surgical® Schedules 2017 First Quarter Earnings Call For April 27, 2017

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the first quarter 2017 on Thursday, April 27, 2017, prior to the market open.

RTI Surgical® Expands Line Of Matrices In International Markets

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, is pleased to announce the expansion of its extensive line of tissue matrices in international markets.

On the Trail of Insider Buying

Execs' activity directs us to 2 promising names.

RTI Surgical, Inc. And Krensavage Partners, LP Reach Settlement Agreement

RTI Surgical Inc. ("RTI") (Nasdaq:RTIX), a global surgical implant company, announced today that it has entered into a settlement agreement with an investor group led by Krensavage Partners, LP (collectively...

RTIX: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/31/2017 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 9.19 "days to cover" versus the median component at 5.13.

RTI Surgical® Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions To Improve Execution And Return To Profitable Growth

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the fourth quarter and full year of 2016.

RTI Surgical® Schedules 2016 Fourth Quarter, Year End Earnings And Conference Call For Feb. 23, 2017

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the fourth quarter and year ended December 31, 2016 on Thursday, Feb.

RTI Surgical® Makes An Inducement Grant To Camille Farhat, New Chief Executive Officer

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, announced today that it made an inducement grant to Camille Farhat.

RTI Surgical Names Camille Farhat Chief Executive Officer (Photo: Business Wire)

RTI Surgical Names Camille Farhat Chief Executive Officer (Photo: Business Wire)

RTI Surgical Inc. ("RTI" or "the company") (Nasdaq: RTIX), a leading global surgical implant company, today announced that Camille Farhat has been named chief executive officer, effective March 15, 2017.

RTI Surgical Extends Deadline For Nominating Directors To The Board

RTI Surgical Extends Deadline For Nominating Directors To The Board

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that its board of directors has voted to extend the deadline for stockholders to provide notice of nominations for election to the...

Robert P. Jordheim Named Interim CEO Of RTI Surgical (Photo: Business Wire)

Robert P. Jordheim Named Interim CEO Of RTI Surgical (Photo: Business Wire)

RTI Surgical (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced that Robert P.

RTI Surgical® Fills The Void In Anterior Cervical Discectomy And Fusion (ACDF) Procedures

RTI Surgical® Fills The Void In Anterior Cervical Discectomy And Fusion (ACDF) Procedures

RTI Surgical (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that its C-Plus™ Peek* IBF System is now indicated for use with allograft, including its proprietary map3 ® cellular...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: HSC, MTLS, PBH, SMCI Downgrades: BURL, CWCO, ELTK, IXYS, PEB, POST, RTIX, TBPH, TISA, TTNP, WMT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

RTI Surgical Announces Additional 510(k) Clearance For The Streamline® OCT System

RTI Surgical Announces Additional 510(k) Clearance For The Streamline® OCT System

RTI Surgical (RTI) (Nasdaq: RTIX), a global surgical implant company, is pleased to announce a recent 510(k) clearance for the Streamline OCT Occipito-Cervico-Thoracic System.

RTI Surgical® Announces 2016 Third Quarter Results

RTI Surgical® Announces 2016 Third Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the third quarter of 2016 as follows: Quarterly Summary: Achieved worldwide...

RTI Surgical® Schedules 2016 Third Quarter Earnings And Conference Call For Oct. 25, 2016

RTI Surgical® Schedules 2016 Third Quarter Earnings And Conference Call For Oct. 25, 2016

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it plans to release financial results from the third quarter 2016 on Tuesday, Oct.

RTI Surgical Collaborates With American Dental Association On Proposed Technical Report No. 1089, Track And Trace For Human Cells, Tissues, And Cellular And Tissue-Based Products

RTI Surgical Collaborates With American Dental Association On Proposed Technical Report No. 1089, Track And Trace For Human Cells, Tissues, And Cellular And Tissue-Based Products

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants, commends the recent work of the American Dental Association (ADA) to improve...

RTI Surgical Receives Regulatory Clearances, Expands Distribution Of NanOss® Bioactive In Australia, Europe

RTI Surgical Receives Regulatory Clearances, Expands Distribution Of NanOss® Bioactive In Australia, Europe

RTI Surgical (RTI) (Nasdaq: RTIX), a global surgical implant company, announced it has recently received regulatory clearance from the Australian Therapeutic Goods Administration (TGA) for nanOss ® Bioactive bone void...

TheStreet Quant Rating: C- (Hold)